Literature DB >> 10343926

Ocular toxicity of mitomycin-C.

D R Hardten1, T W Samuelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343926     DOI: 10.1097/00004397-199903920-00007

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  6 in total

1.  Complications of management in primary acquired melanosis with atypia.

Authors:  Devron H Char
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

2.  Effects of intraoperative steroid injection on the outcome of pterygium surgery.

Authors:  A Kheirkhah; R Nazari; H Safi; H Ghassemi; M J Behrouz; V K Raju
Journal:  Eye (Lond)       Date:  2013-07-26       Impact factor: 3.775

3.  Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment.

Authors:  D H Ma; L C See; S B Liau; R J Tsai
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

4.  Mitomycin C for pterygium: long term evaluation.

Authors:  F Raiskup; A Solomon; D Landau; M Ilsar; J Frucht-Pery
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

5.  In vitro and in vivo comparison of two suprachoroidal shunts.

Authors:  Julius T Oatts; Ze Zhang; Harry Tseng; M Bruce Shields; John H Sinard; Nils A Loewen
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

6.  SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon's Capsule Fibroblasts.

Authors:  Yuanyuan Guo; Shouxiang Ni; Weiyan Zhou; Jiangping Hou; Jiaquan Shen
Journal:  J Ophthalmol       Date:  2020-02-10       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.